Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 8;4(2):e323. doi: 10.1212/NXI.0000000000000323. eCollection 2017 Mar.

¹ Department of Neurology (G.B., M.A., S.I., G.S., T.B.), Department of Neuroradiology (L.-M.W.), and Department of Psychiatry (G.S.-M.), Medical University of Innsbruck; and Department of Neurology (D.L., S.K.), Landeskrankenhaus Rankweil, Austria.

No abstract available